malignant anemia

1. Methods SF levels were detected with chemiluminescent technique, in the elderly malignant tumor patients with anemia and normal controls.
   方法以化学发光法测定恶性肿瘤贫血病人及对照组血清铁蛋白水平。
2. Influence of malignant tumor anemia on the malignancy patients 'quality of life and survival
   癌性贫血对恶性肿瘤患者生活质量及生存期的影响
3. Methods The therapeutic effects of 18 cases of malignant hematological disease with high dose chemotherapy were observed and divided into two groups ( one group treated with isolated blood transfusion and the other group treated with 2 million unit rhEPO once a week for chemotherapy-related anemia).
   方法18例恶性血液病大剂量化疗患者，前后自身对照单纯输血和应用rhEPO（益比奥）2万U，每周1次，观察其防治化疗相关性贫血疗效。
4. The effect of erythropoietin in treating the malignant tumour anemia
   红细胞生成素治疗恶性肿瘤贫血的疗效观察
5. Among them 4 cases of malignant tumors of spleen had general malaise, anemia and loss of body weight.
   9例原发性脾肿瘤均有不同程度的左上腹部疼痛，其中4例脾恶性肿瘤伴有乏力、贫血、体重减轻。
6. Detection of Red Blood Cell Volume Distribution Width of Malignant Anemia Patients
   恶性肿瘤贫血患者红细胞体积分布宽度检测探讨
7. The following conditions were excluded: severe hepatic and renal dysfunction, malnutrition, malignant tumour, malignant anemia, diabetes.
   排除严重肝肾功能不全、营养不良、严重恶性疾病（如恶性肿瘤）、恶性贫血、糖尿病病人。
8. Treatment of Malignant Tumor Anemia ( MTA) by Erythropoietin ( EPO) Combined with Chemotherapy
   促红细胞生成素（EPO）联合化疗治疗癌症相关性贫血
9. Objective: To study the significance of multiple diseases including malignant tumors in the pathogenesis of iron deficiency anemia ( IDA).
   目的：通过对确诊为缺铁性贫血的病例进行病因学分析，探讨多病变和恶性肿瘤在缺铁性贫血发病中的重要性。
10. Multiple myeloma is a malignant plasma cell disorder. And it is characterized by heterogeneous anemia, bone disease, renal impairment, hypercalcaemia and infections due to patchy accumulation of malignant plasma cells within the marrow microenvironment.
    多发性骨髓瘤（MM）是一种浆细胞恶性增殖性疾病，其特点是恶性浆细胞在骨髓微环境中不规则积聚引起的不同程度贫血、骨破坏、肾功能不全、高钙血症和感染。

noun

1. a chronic progressive anemia of older adults

   Synonym:    pernicious anemiapernicious anaemiamalignant anaemia